Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction

AIMS: Spironolactone has been shown to improve outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). We investigated whether the discharge use of spironolactone could be associated with better long‐term outcomes among patients with HF with mid‐range EF (HFmrEF). METHODS A...

Descripción completa

Detalles Bibliográficos
Autores principales: Enzan, Nobuyuki, Matsushima, Shouji, Ide, Tomomi, Kaku, Hidetaka, Higo, Taiki, Tsuchihashi‐Makaya, Miyuki, Tsutsui, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083406/
https://www.ncbi.nlm.nih.gov/pubmed/31951680
http://dx.doi.org/10.1002/ehf2.12571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083406/
https://www.ncbi.nlm.nih.gov/pubmed/31951680
http://dx.doi.org/10.1002/ehf2.12571

Ejemplares similares